share_log

Lifeist Initiates Restructuring Proceedings for CannMart Labs Inc.

Lifeist Initiates Restructuring Proceedings for CannMart Labs Inc.

Lifeist 啓動了 CannMart Labs Inc. 的重組程序
GlobeNewswire ·  04/03 20:57

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has commenced restructuring proceedings pursuant to the Bankruptcy and Insolvency Act for one of its wholly owned subsidiaries, CannMart Labs Inc. ("CannMart Labs"). The restructuring of CannMart Labs is part of a broader strategic initiative to enhance the company's operational effectiveness while maintaining its commitment to innovation and growth. It is important to note that this restructuring does not impact CannMart Inc., Lifeist's flagship subsidiary and a leading distributor of licensed and in-house branded adult-use cannabis and cannabis-derived products in Canada.

多倫多,2024年4月3日(環球新聞專線)——利用科學和技術進步建立改變人類健康的突破性企業的健康科技公司Lifeist Wellness Inc.(“Lifeist” 或 “公司”)(多倫多證券交易所股票代碼:LFST)(法蘭克福:M5B)(OTCMKTS:LFSWF)今天宣佈,它已根據《破產和破產法》啓動重組程序其全資子公司之一——CannMart Labs Inc.(“CannMart Labs”)。CannMart Labs的重組是更廣泛的戰略計劃的一部分,該計劃旨在提高公司的運營效率,同時保持其對創新和增長的承諾。值得注意的是,此次重組不會影響CannMart Inc.,這是Lifeist的旗艦子公司,也是加拿大授權和內部品牌成人用大麻和大麻衍生產品的領先分銷商。

"Following a thorough financial and strategic review, we believe that it is in the best interest of shareholders for CannMart Labs alone to enter into restructuring proceedings in order to address its obligations and contributions to Lifeist's balance sheet," said Meni Morim, CEO of Lifeist. "We are fully committed to streamlining the operations of our cannabis divisions to better meet the present moment in the industry and are optimistic that this restructuring of CannMart Labs will allow Lifeist's cannabis operations to unlock greater shareholder value. We expect that these proceedings will have no impact on the day-to-day operations of CannMart Inc. or any of our other operating divisions."

Lifeist首席執行官梅尼·莫里姆表示:“經過全面的財務和戰略審查,我們認爲,光靠CannMart Labs進入重組程序以解決其對Lifeist資產負債表的義務和貢獻,符合股東的最大利益。”“我們完全致力於精簡大麻部門的運營,以更好地適應該行業的現狀,並樂觀地認爲,CannMart Labs的重組將使Lifeist的大麻業務能夠釋放更大的股東價值。我們預計,這些訴訟不會對CannMart Inc.或我們任何其他運營部門的日常運營產生任何影響。”

Following the vote of shareholders at the Company's recent annual general and special meeting rejecting the sale of the CannMart Group, Lifeist's cannabis operating division, management undertook a bottom-up review of the businesses to identify opportunities for optimization and improvement. The decision to restructure CannMart Labs was made with input from advisors and legal counsel, with the objective of achieving sustainable growth toward future profitability for the benefit of all Lifeist shareholders. This strategic move is part of a broader commitment to ensure the long-term success of the public company.

在公司最近的年度股東大會和特別會議上,股東投票拒絕出售Lifeist的大麻運營部門CannMart集團,此後,管理層對這些業務進行了自下而上的審查,以確定優化和改進的機會。重組CannMart Labs的決定是在顧問和法律顧問的意見下做出的,目的是實現可持續增長,實現未來的盈利能力,造福所有Lifeist股東。這一戰略舉措是確保上市公司長期成功的更廣泛承諾的一部分。

While the restructuring does not apply to CannMart Inc., this strategic move aims to optimize operational efficiency and streamline the company's focus in alignment with its long-term vision. The decision to initiate restructuring proceedings for CannMart Labs underscores Lifeist's dedication to adaptability and resilience in navigating the dynamic landscape of the cannabis industry. By optimizing the operational structure of CannMart Labs, Lifeist aims to bolster its ability to deliver innovative wellness solutions that positively impact the lives of its customers.

儘管重組不適用於CannMart Inc.,但這一戰略舉措旨在優化運營效率並精簡公司的重點,使其與其長期願景保持一致。啓動CannMart Labs重組程序的決定凸顯了Lifeist在大麻行業動態格局中對適應性和彈性的承諾。通過優化CannMart Labs的運營結構,Lifeist旨在增強其提供創新健康解決方案的能力,從而對客戶的生活產生積極影響。

Lifeist remains steadfast in its mission to leverage advancements in science and technology to build breakthrough ventures that transform human wellness. The Company is confident that the restructuring of Labs will further strengthen its position as a leader in the health-tech industry and pave the way for continued growth and innovation.

Lifeist堅定不移地履行其使命,即利用科學和技術的進步來建立突破性企業,改變人類健康。該公司相信,實驗室的重組將進一步鞏固其作爲健康科技行業領導者的地位,併爲持續增長和創新鋪平道路。

About Lifeist Wellness Inc.

關於 Lifeist Wellness

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories.

Lifeist處於疫情後健康革命的最前沿,利用科學和技術的進步來建立突破性公司,改變人類健康。投資組合業務部門包括:開發和銷售細胞健康創新產品的生物科學和消費者健康公司Mikra;CannMart,該公司經營B2B批發分銷業務,促進向加拿大省政府控制委員會銷售休閒大麻,包括生產高利潤大麻2.0產品的BHO提取設施CannMart Labs;以及澳大利亞最大的蒸發器和配件在線零售商之一澳大利亞Vapes。

Information on Lifeist and its businesses can be accessed through the links below:

有關Lifeist及其業務的信息可以通過以下鏈接訪問:

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com

聯繫人:
Meni Morim
首席執行官
Lifeist健康公司
Ph:647-362-0390
電子郵件:ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任,也未以任何方式批准或不批准本新聞稿的內容。

Forward Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新聞稿包含適用證券法所指的 “前瞻性信息”。此處包含的所有非歷史性陳述均包含前瞻性信息。前瞻性信息可以通過單詞或短語來識別,例如 “可能”、“期望”、“可能”、“應該”、“將”、“計劃”、“預期”、“打算”、“潛在”、“提議”、“估計”、“相信” 或這些術語的否定詞、表達方式和語法變體,或某些事件或條件 “可能” 或 “將” 發生的陳述。

The forward-looking information contained herein, including, without limitation, statements related to the contemplated restructuring of CannMart Labs are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, the restructuring can be completed in the short term and, upon completion, achieve the intended economic benefits for the Company, and other wholly-owned subsidiaries can become profitable in the short-term, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the inability of the Company to complete a feasible and economic restructuring of CannMart Inc., in a timely manner, if at all, the Company's failure to develop its businesses as anticipated and to realize on the anticipated benefits from its increased focus on its other operating businesses unanticipated changes to current regulations that would adversely impact its businesses, unforeseen developments that would delay its businesses the ability to sell newly developed products, the risk that the expected demand for products in general and those of its businesses in particular does not develop as anticipated and risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR+ profile at . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

此處包含的前瞻性信息,包括但不限於與CannMart Labs計劃重組有關的陳述,均截至本新聞稿發佈之日作出,基於管理層在發表此類聲明時認爲合理的假設,包括但不限於重組可以在短期內完成,重組完成後,實現公司的預期經濟利益,其他全資子公司可以在短期內實現盈利,以及其他注意事項據信這在當時情況下是適當的。儘管根據管理層目前獲得的信息,我們認爲這些假設是合理的,但無法保證此類預期會被證明是正確的。就其性質而言,前瞻性信息受固有的風險和不確定性的影響,這些風險和不確定性可能是一般性的,也可能是具體的,這些風險和不確定性可能導致預期、預測、預測、預測或結論不準確,假設可能不正確,目標、戰略目標和優先事項無法實現。各種因素,包括已知和未知的風險,其中許多是我們無法控制的,可能導致實際業績與本新聞稿中的前瞻性信息存在重大差異。這些因素包括但不限於:公司無法及時(如果有的話)完成對CannMart Inc.的可行經濟重組,該公司未能按預期發展業務,也未能實現其越來越關注其他運營業務所帶來的預期收益,對現行法規的意外變化將對其業務產生不利影響,不可預見的事態發展將延遲其業務銷售新開發產品的能力,預期需求的風險對於總體而言,產品,尤其是其業務的產品未按預期發展,風險與公司執行業務戰略的能力及其可帶來的收益有關。其他風險因素還可以在公司SEDAR+簡介下提交的公司當前的MD&A中找到,網址爲。提醒讀者不要過分依賴前瞻性信息。除非適用法律要求,否則公司沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。本新聞稿中包含的前瞻性陳述受本警示聲明的明確限制。

Source: Lifeist Wellness Inc.

資料來源:Lifeist Wellness


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論